Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congressmen Call On GAO To Update Behind-The-Counter Class Investigation

This article was originally published in The Tan Sheet

Executive Summary

The Government Accountability Office should update its 1995 study of behind-the-counter drug regulatory schemes in o0ther countries to better educate FDA as it considers a third class of drugs in the U.S., members of the House Energy and Commerce Committee say in a Jan. 16 letter to the GAO

You may also be interested in...



Behind-The-Counter Class Requires Investment, With Payoff Unclear– GAO

A behind-the-counter drug class in the U.S. is not feasible unless the government addresses some significant logistical challenges, the Government Accountability Office says

Behind-The-Counter Class Requires Investment, With Payoff Unclear– GAO

A behind-the-counter drug class in the U.S. is not feasible unless the government addresses some significant logistical challenges, the Government Accountability Office says

Behind-The-Counter Class Requires Investment, With Payoff Unclear– GAO

A behind-the-counter drug class in the U.S. is not feasible unless the government addresses some significant logistical challenges, the Government Accountability Office says

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

PS101292

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel